Grünenthal Gmbh
Clinical trials sponsored by Grünenthal Gmbh, explained in plain language.
-
New knee shot could ease arthritis pain for months
Symptom relief CompletedThis study tested a single injection of the drug RTX-GRT7039 in 466 adults with knee osteoarthritis pain that wasn't helped by standard treatments. The goal was to see if the injection reduces pain better than a placebo (fake shot). Researchers measured pain changes at 12 and 26 …
Phase: PHASE3 • Sponsor: Grünenthal GmbH • Aim: Symptom relief
Last updated May 15, 2026 12:07 UTC
-
New knee injection shows promise for osteoarthritis pain relief
Symptom relief CompletedThis study tested the safety of an experimental injection called RTX-GRT7039 for people with moderate to severe knee pain from osteoarthritis. 714 adults who did not get enough relief from standard treatments received one or two injections. The main goal was to check for side eff…
Phase: PHASE3 • Sponsor: Grünenthal GmbH • Aim: Symptom relief
Last updated May 15, 2026 11:53 UTC
-
New knee shot could ease arthritis pain without surgery
Symptom relief CompletedThis study tested whether an experimental drug called RTX-GRT7039, given as a shot into the knee, can reduce pain in people with knee osteoarthritis who haven't gotten enough relief from standard treatments. About 469 adults took part. The goal was to see if the injection improve…
Phase: PHASE3 • Sponsor: Grünenthal GmbH • Aim: Symptom relief
Last updated May 04, 2026 16:24 UTC
-
First step for DMD drug: safety check in healthy volunteers
Knowledge-focused CompletedThis early-stage trial tested a single dose of a new drug called GRT6019 in 18 healthy men to see if it is safe and how the body processes it. The study also looked at whether food changes how the drug works. This is a first step before testing the drug in people with Duchenne Mu…
Phase: PHASE1 • Sponsor: Grünenthal GmbH • Aim: Knowledge-focused
Last updated May 17, 2026 06:51 UTC